Neuroendocrine tumours are a family of rare tumours produced by various (endocrine) glands in the body. There are many types of neuroendocrine tumours.
Neuroendocrine tumours (NETs) are a family of rare tumours produced by various (endocrine) glands in the body, including the digestive tube, the pancreas, the bronchus, the adrenal glands and the thyroid. They develop in a variety of ways, often very slowly.
These tumours vary in aggressiveness, requiring a range of treatments depending on the level of aggressiveness and the gland in which they originated. As a result, and given their rarity, they therefore need to be treated by an expert multidisciplinary team. The Eugène Marquis Centre is an expert centre for the treatment of NETs, as its doctors (medical oncologists, nuclear medical specialists and radiologists) take part in multidisciplinary team meetings on NETs, assist the Collaborative Research Group on Neuroendocrine Tumours (GTE) [Groupe collaboratif de recherche sur les Tumeurs Endocrines] and are involved in clinical research on NETs.
The Eugène Marquis Centre is part of the National Neuroendocrine Tumour Care Network (RENATEN) [Réseau National de prise en charge des Tumeurs neuro-Endocrines].
Through multidisciplinary team meetings on neuroendocrine tumours, the Eugène Marquis Centre has developed a specialist treatment strategy for these rare tumours. A hereditary assessment is carried out for all patients to check for a history of family illness. The assessment is based on the patient’s medical history and that of their family members.
Surgery may be carried out to completely remove the tumour. Surgery may also be used to treat local and/or metastatic reoccurrences. Metabolic radiotherapy or chemotherapy is also a possible option, depending on the tumours.
Regular follow-up appointments with a specialist are essential to track any changes, in particular through regular imaging.
Dr PRACHT Marc Doctor OncologistMore